Adaptable Physical Therapy And Consulting, Llc - Medicare Physical Therapist in Barrington, RI

Adaptable Physical Therapy And Consulting, Llc is a medicare enrolled "Physical Therapist" provider in Barrington, Rhode Island. Their current practice location is 4 Woodbine Ave, Barrington, Rhode Island. You can reach out to their office (for appointments etc.) via phone at (401) 903-2442.

Adaptable Physical Therapy And Consulting, Llc is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Adaptable Physical Therapy And Consulting, Llc is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1689299547.

Contact Information

Adaptable Physical Therapy And Consulting, Llc
4 Woodbine Ave,
Barrington, RI 02806-1030
(401) 903-2442
Not Available



Healthcare Provider's Profile

Full NameAdaptable Physical Therapy And Consulting, Llc
TypeFacility
SpecialityPhysical Therapist
Location4 Woodbine Ave, Barrington, Rhode Island
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1689299547
  • Provider Enumeration Date: 06/16/2020
  • Last Update Date: 06/16/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 0749604437
  • Enrollment ID: O20200728002976

Medical Identifiers

Medical identifiers for Adaptable Physical Therapy And Consulting, Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1689299547NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
225100000XPhysical Therapist (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Adaptable Physical Therapy And Consulting, Llc acts as a billing entity for following providers:
Provider NameNicole Rawnsley
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1649646274
PECOS PAC ID: 8224347596
Enrollment ID: I20151028000065

News Archive

Weekend reading: Spiritual bedside manner; Cancer and the environment; Doctors' fears about bringing up hospice

Every week reporter Ankita Rao selects interesting reading from around the Web.

U.S. stands divided on Obama with positive and negative ratings

As the summer winds down, President Obama's job numbers continue to move in a downward way. In June, 54% of U.S. adults gave him positive ratings and 46% gave the president negative marks.

Children's vaccine for pneumococcal disease does not offer full protection

The vaccine given to children to immunise against serious pneumococcal disease does not offer full protection, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden, finding that the number of cases diagnosed has tripled over the past 50 years.

SAFC Pharma's Pharmorphix Solid State Research Laboratories installs new single crystal X-ray diffraction system

SAFC Pharma®, a business segment of SAFC®, a member of the Sigma-Aldrich® Group, today announced that its Pharmorphix® Solid State Research Laboratories in Cambridge, UK, have installed a new single crystal X-ray diffraction system. The Oxford Diffraction SuperNova(TM) system, which can determine the crystal structures from the most challenging crystal samples, is the first industrial installation of this state-of-the-art instrumentation anywhere in the world.

FDA approves scan to detect Alzheimer's disease early

The test uses a chemical called florbetapir, known by the brand name Amyvid, which is a radioactive agent that tags clumps of a sticky substance called an amyloid. Amyloid proteins are hallmarks of Alzheimer's disease. The chemical, which costs $1,600 per dose, then is detected using a brain imaging technique called positron emission tomography, known as PET scans. For patients who already have some symptoms of cognitive decline, a positive scan suggests that moderate to frequent amyloid plaques are present in the brain, which is consistent with Alzheimer's disease.

Read more Medical News

› Verified 7 days ago

Provider NameKristen Tracy Gross
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1043703390
PECOS PAC ID: 7911321609
Enrollment ID: I20200728003217

News Archive

Weekend reading: Spiritual bedside manner; Cancer and the environment; Doctors' fears about bringing up hospice

Every week reporter Ankita Rao selects interesting reading from around the Web.

U.S. stands divided on Obama with positive and negative ratings

As the summer winds down, President Obama's job numbers continue to move in a downward way. In June, 54% of U.S. adults gave him positive ratings and 46% gave the president negative marks.

Children's vaccine for pneumococcal disease does not offer full protection

The vaccine given to children to immunise against serious pneumococcal disease does not offer full protection, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden, finding that the number of cases diagnosed has tripled over the past 50 years.

SAFC Pharma's Pharmorphix Solid State Research Laboratories installs new single crystal X-ray diffraction system

SAFC Pharma®, a business segment of SAFC®, a member of the Sigma-Aldrich® Group, today announced that its Pharmorphix® Solid State Research Laboratories in Cambridge, UK, have installed a new single crystal X-ray diffraction system. The Oxford Diffraction SuperNova(TM) system, which can determine the crystal structures from the most challenging crystal samples, is the first industrial installation of this state-of-the-art instrumentation anywhere in the world.

FDA approves scan to detect Alzheimer's disease early

The test uses a chemical called florbetapir, known by the brand name Amyvid, which is a radioactive agent that tags clumps of a sticky substance called an amyloid. Amyloid proteins are hallmarks of Alzheimer's disease. The chemical, which costs $1,600 per dose, then is detected using a brain imaging technique called positron emission tomography, known as PET scans. For patients who already have some symptoms of cognitive decline, a positive scan suggests that moderate to frequent amyloid plaques are present in the brain, which is consistent with Alzheimer's disease.

Read more Medical News

› Verified 7 days ago

Provider NameTracy Anne Mckenna
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1588271738
PECOS PAC ID: 7517350002
Enrollment ID: I20220204001150

News Archive

Weekend reading: Spiritual bedside manner; Cancer and the environment; Doctors' fears about bringing up hospice

Every week reporter Ankita Rao selects interesting reading from around the Web.

U.S. stands divided on Obama with positive and negative ratings

As the summer winds down, President Obama's job numbers continue to move in a downward way. In June, 54% of U.S. adults gave him positive ratings and 46% gave the president negative marks.

Children's vaccine for pneumococcal disease does not offer full protection

The vaccine given to children to immunise against serious pneumococcal disease does not offer full protection, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden, finding that the number of cases diagnosed has tripled over the past 50 years.

SAFC Pharma's Pharmorphix Solid State Research Laboratories installs new single crystal X-ray diffraction system

SAFC Pharma®, a business segment of SAFC®, a member of the Sigma-Aldrich® Group, today announced that its Pharmorphix® Solid State Research Laboratories in Cambridge, UK, have installed a new single crystal X-ray diffraction system. The Oxford Diffraction SuperNova(TM) system, which can determine the crystal structures from the most challenging crystal samples, is the first industrial installation of this state-of-the-art instrumentation anywhere in the world.

FDA approves scan to detect Alzheimer's disease early

The test uses a chemical called florbetapir, known by the brand name Amyvid, which is a radioactive agent that tags clumps of a sticky substance called an amyloid. Amyloid proteins are hallmarks of Alzheimer's disease. The chemical, which costs $1,600 per dose, then is detected using a brain imaging technique called positron emission tomography, known as PET scans. For patients who already have some symptoms of cognitive decline, a positive scan suggests that moderate to frequent amyloid plaques are present in the brain, which is consistent with Alzheimer's disease.

Read more Medical News

› Verified 7 days ago

Provider NameLeah Kelleher
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1639545403
PECOS PAC ID: 7214397694
Enrollment ID: I20230717002773

News Archive

Weekend reading: Spiritual bedside manner; Cancer and the environment; Doctors' fears about bringing up hospice

Every week reporter Ankita Rao selects interesting reading from around the Web.

U.S. stands divided on Obama with positive and negative ratings

As the summer winds down, President Obama's job numbers continue to move in a downward way. In June, 54% of U.S. adults gave him positive ratings and 46% gave the president negative marks.

Children's vaccine for pneumococcal disease does not offer full protection

The vaccine given to children to immunise against serious pneumococcal disease does not offer full protection, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden, finding that the number of cases diagnosed has tripled over the past 50 years.

SAFC Pharma's Pharmorphix Solid State Research Laboratories installs new single crystal X-ray diffraction system

SAFC Pharma®, a business segment of SAFC®, a member of the Sigma-Aldrich® Group, today announced that its Pharmorphix® Solid State Research Laboratories in Cambridge, UK, have installed a new single crystal X-ray diffraction system. The Oxford Diffraction SuperNova(TM) system, which can determine the crystal structures from the most challenging crystal samples, is the first industrial installation of this state-of-the-art instrumentation anywhere in the world.

FDA approves scan to detect Alzheimer's disease early

The test uses a chemical called florbetapir, known by the brand name Amyvid, which is a radioactive agent that tags clumps of a sticky substance called an amyloid. Amyloid proteins are hallmarks of Alzheimer's disease. The chemical, which costs $1,600 per dose, then is detected using a brain imaging technique called positron emission tomography, known as PET scans. For patients who already have some symptoms of cognitive decline, a positive scan suggests that moderate to frequent amyloid plaques are present in the brain, which is consistent with Alzheimer's disease.

Read more Medical News

› Verified 7 days ago

Provider NameShaelyn O'reilly Bouchard
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1730557232
PECOS PAC ID: 3375904592
Enrollment ID: I20230816000380

News Archive

Weekend reading: Spiritual bedside manner; Cancer and the environment; Doctors' fears about bringing up hospice

Every week reporter Ankita Rao selects interesting reading from around the Web.

U.S. stands divided on Obama with positive and negative ratings

As the summer winds down, President Obama's job numbers continue to move in a downward way. In June, 54% of U.S. adults gave him positive ratings and 46% gave the president negative marks.

Children's vaccine for pneumococcal disease does not offer full protection

The vaccine given to children to immunise against serious pneumococcal disease does not offer full protection, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden, finding that the number of cases diagnosed has tripled over the past 50 years.

SAFC Pharma's Pharmorphix Solid State Research Laboratories installs new single crystal X-ray diffraction system

SAFC Pharma®, a business segment of SAFC®, a member of the Sigma-Aldrich® Group, today announced that its Pharmorphix® Solid State Research Laboratories in Cambridge, UK, have installed a new single crystal X-ray diffraction system. The Oxford Diffraction SuperNova(TM) system, which can determine the crystal structures from the most challenging crystal samples, is the first industrial installation of this state-of-the-art instrumentation anywhere in the world.

FDA approves scan to detect Alzheimer's disease early

The test uses a chemical called florbetapir, known by the brand name Amyvid, which is a radioactive agent that tags clumps of a sticky substance called an amyloid. Amyloid proteins are hallmarks of Alzheimer's disease. The chemical, which costs $1,600 per dose, then is detected using a brain imaging technique called positron emission tomography, known as PET scans. For patients who already have some symptoms of cognitive decline, a positive scan suggests that moderate to frequent amyloid plaques are present in the brain, which is consistent with Alzheimer's disease.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Adaptable Physical Therapy And Consulting, Llc is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Adaptable Physical Therapy And Consulting, Llc
4 Woodbine Ave,
Barrington, RI 02806-1030

Ph: (401) 903-2442
Adaptable Physical Therapy And Consulting, Llc
4 Woodbine Ave,
Barrington, RI 02806-1030

Ph: (401) 903-2442

News Archive

Weekend reading: Spiritual bedside manner; Cancer and the environment; Doctors' fears about bringing up hospice

Every week reporter Ankita Rao selects interesting reading from around the Web.

U.S. stands divided on Obama with positive and negative ratings

As the summer winds down, President Obama's job numbers continue to move in a downward way. In June, 54% of U.S. adults gave him positive ratings and 46% gave the president negative marks.

Children's vaccine for pneumococcal disease does not offer full protection

The vaccine given to children to immunise against serious pneumococcal disease does not offer full protection, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden, finding that the number of cases diagnosed has tripled over the past 50 years.

SAFC Pharma's Pharmorphix Solid State Research Laboratories installs new single crystal X-ray diffraction system

SAFC Pharma®, a business segment of SAFC®, a member of the Sigma-Aldrich® Group, today announced that its Pharmorphix® Solid State Research Laboratories in Cambridge, UK, have installed a new single crystal X-ray diffraction system. The Oxford Diffraction SuperNova(TM) system, which can determine the crystal structures from the most challenging crystal samples, is the first industrial installation of this state-of-the-art instrumentation anywhere in the world.

FDA approves scan to detect Alzheimer's disease early

The test uses a chemical called florbetapir, known by the brand name Amyvid, which is a radioactive agent that tags clumps of a sticky substance called an amyloid. Amyloid proteins are hallmarks of Alzheimer's disease. The chemical, which costs $1,600 per dose, then is detected using a brain imaging technique called positron emission tomography, known as PET scans. For patients who already have some symptoms of cognitive decline, a positive scan suggests that moderate to frequent amyloid plaques are present in the brain, which is consistent with Alzheimer's disease.

Read more News

› Verified 7 days ago


Physical Therapist in Barrington, RI

Christopher Grant,
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 147 County Rd, 301a, Barrington, RI 02806
Phone: 401-643-1776    Fax: 401-694-0965
Lepre Physical Therapy Of Barrington,llc
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 310 Maple Ave, Barrington, RI 02806
Phone: 401-247-0500    Fax: 401-247-0507
Dr. Isaac Keohan Lapides, DPT
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 18 Maple Ave Ste 1, Barrington, RI 02806
Phone: 401-643-1776    
Mrs. Mary Thomas Hanchar, MSPT
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 25 Frederick Dr, Barrington, RI 02806
Phone: 401-246-0190    
Dr. Jeremy Jay Mcvay, DPT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 18 Maple Ave Ste 1, Barrington, RI 02806
Phone: 401-643-1776    Fax: 401-694-0965
Cynthia Moore Thomsen, PT
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 28 Upland Way, Barrington, RI 02806
Phone: 401-246-1001    
Mcvay Physical Therapy
Physical Therapist
Medicare: Medicare Enrolled
Practice Location: 18 Maple Ave Ste 1, Barrington, RI 02806
Phone: 401-643-1776    Fax: 401-694-0965

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.